Cancers, Vol. 11, Pages 1892: Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGF β2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up
Conclusion. Intratumorally administered OT101 exhibits clinically meaningful single-agent activity and induces durable CR/PR/SD in R/R HGG patients.
Source: Cancers - Category: Cancer & Oncology Authors: Fatih M. Uckun Sanjive Qazi Larn Hwang Vuong N. Trieu Tags: Article Source Type: research
More News: Astrocytoma | Brain Tumor | Cancer | Cancer & Oncology | Clinical Trials | Glioma | MRI Scan | PET Scan | Statistics